[製剤] Lonzaが 非経口剤の無菌製剤製造施設をノバルティスより取得

・Facility in Stein (CH) will complement Lonza Pharma & Biotech’s current parenteral drug product offering in Basel (CH)
・First facility for Lonza’s Drug Product Services (DPS) to cover sterile manufacturing for clinical production and commercial launches
・Management and operations teams will be retained and Lonza will manufacture for Novartis at the facility

（リンク先より全文をご覧いただけます/英語）

• リリース情報を見る